Loading...
Loading...
Application UK00801547228 · DO-NOT-DISPLAY

| Application Number | UK00801547228 |
| Status | DO-NOT-DISPLAY |
| Owner | oNKo-innate Pty Ltd |
| Filed | 2020-07-23 |
| Registered | 2021-01-20 |
| Renewal Due | 2030-07-23 |
| Type | Individual |
| Feature | Figurative |
| Attorney | See claim section below |
UK00801547228 has a current status of DO-NOT-DISPLAY.
The specification below is taken directly from the filed record at the UK IPO for each Nice class this trademark is registered in.
Pharmaceutical drugs; pharmaceutical preparations; stem cells for medical purposes; living cells for medical use; pharmaceutical and biological preparations for the treatment of cancer; biological products for medical use; chemicals for pharmaceutical use.
Scientific research; pharmaceutical research, development and testing services; preparation of scientific reports; advisory services relating to immunological product development and testing; scientific research, design, analysis and testing of pharmaceutical products; conducting scientific and medical research and clinical trials; research in the field of immunology and cancer treatment; scientific research and testing in the field of natural killer cells; provision of scientific information; scientific and technical analysis; scientific consultancy; scientific research in the field of pharmacy; medical research; research and development of products; research relating to pharmaceuticals.
This figurative mark is indexed under the following Vienna categories by the UK IPO:
This device mark (application number UK00801547228) is a do-not-display trademark on the UK IPO register, filed by oNKo-innate Pty Ltd on 23 July 2020, with registration granted on 20 January 2021. It is due to expire on 23 July 2030.
This mark is recorded under multiple classes: Class 5 (pharmaceuticals & medical preparations); Class 42 (scientific, IT & design services).
The trademark is represented by Herbert Smith Freehills.
No — the UK IPO records the status of UK trademark UK00801547228 as do-not-display.
UK trademark UK00801547228 is recorded in Class 5 (pharmaceuticals & medical preparations); Class 42 (scientific, IT & design services). The filed specification reads: Class 5: Pharmaceutical drugs; pharmaceutical preparations; stem cells for medical purposes; living cells for medical use; pharmaceutical and biological preparations for the treatment of cancer; biological products for medical use; chemicals for pharmaceutical use. | Class 42: Scientific research; pharmaceutical res…
UK trademark UK00801547228 was filed at the UK IPO on 23 July 2020 and registered on 20 January 2021.
UK trademark UK00801547228 is currently recorded as valid until 23 July 2030, at which point it will need to be renewed with the UK IPO to remain in force.
Herbert Smith Freehills is listed as the attorney / representative of record for UK trademark UK00801547228 on the UK IPO register.
This trademark has an attorney of record listed on the UK register. The firm has not yet claimed its listing on Trademark Dashboard.
UK trademark data is supplied by the Intellectual Property Office under the Open Government Licence v3.0.
The “About This Trademark” summary and FAQ above are AI-generated from the register data shown on this page. They are factual summaries only — always verify details against the official register before making legal decisions.